Research shows bimagrumab may prevent muscle and bone loss associated with weight loss medications like Wegovy, offering hope ...

Intermittent fasting is becoming increasingly popular. But is it helpful for weight loss and other medical conditions?

Understanding the molecular pathology ... insulin, c-peptide, glucagon, gastrin, pancreatic polypeptide, prolactin, insulin-like growth factor 1 (for detection of growth-hormone-producing tumors ...

Evidence for this mechanism lies in the fact that the protein composition ... of glucagon secretion. In addition to glucagon, a novel proglucagon-derived peptide, proglucagon 1-61 (PG 1-61) comprised ...

To identify and confirm the mechanisms of D3, transcriptome analysis of ileum and molecular approaches on three animal ... Polypeptides such as glucagon-like peptide-1 (GLP-1) analogue used to prevent ...

Models based on genetically determined set points explained some of the weight control mechanisms, but exact molecular underpinnings remained ... cholecystokinin; PYY, peptide YY; GLP-1, glucagon-like ...

Feb. 5, 2025 /PRNewswire/ -- The American College of Clinical Pharmacology ® (ACCP) published a recent Position Paper entitled "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor ...

Background: Despite their potential, Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have not been well studied in cardiac amyloidosis (CA) as randomized trials on GLP-1 RA have excluded patients ...

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become ...